- Home
- RNW vs NVCR Comparison
RNW vs NVCR Comparison
Compare RNW & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNW
- NVCR
- Stock Information
- Founded
- RNW 2011
- NVCR 2000
- Country
- RNW United Kingdom
- NVCR Switzerland
- Employees
- RNW N/A
- NVCR N/A
- Industry
- RNW Electric Utilities: Central
- NVCR Medical/Dental Instruments
- Sector
- RNW Utilities
- NVCR Health Care
- Exchange
- RNW Nasdaq
- NVCR Nasdaq
- Market Cap
- RNW 2.2B
- NVCR 1.9B
- IPO Year
- RNW N/A
- NVCR 2015
- Fundamental
- Price
- RNW $6.21
- NVCR $15.58
- Analyst Decision
- RNW Strong Buy
- NVCR Buy
- Analyst Count
- RNW 1
- NVCR 6
- Target Price
- RNW $7.50
- NVCR $34.17
- AVG Volume (30 Days)
- RNW 915.5K
- NVCR 736.7K
- Earning Date
- RNW 06-04-2025
- NVCR 04-24-2025
- Dividend Yield
- RNW N/A
- NVCR N/A
- EPS Growth
- RNW N/A
- NVCR N/A
- EPS
- RNW 0.04
- NVCR N/A
- Revenue
- RNW $1,006,524,942.00
- NVCR $605,220,000.00
- Revenue This Year
- RNW N/A
- NVCR $3.14
- Revenue Next Year
- RNW $38.75
- NVCR $10.63
- P/E Ratio
- RNW $158.29
- NVCR N/A
- Revenue Growth
- RNW N/A
- NVCR 18.82
- 52 Week Low
- RNW $5.15
- NVCR $11.70
- 52 Week High
- RNW $7.49
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- RNW 55.37
- NVCR 34.24
- Support Level
- RNW $6.03
- NVCR $15.49
- Resistance Level
- RNW $6.23
- NVCR $17.06
- Average True Range (ATR)
- RNW 0.25
- NVCR 1.06
- MACD
- RNW 0.05
- NVCR -0.01
- Stochastic Oscillator
- RNW 96.95
- NVCR 20.42
About RNW ReNew Energy Global plc
ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.